| Product Name | MF | CAS | Details |
|---|
| 1-Bromo-2,3,4,6-tetra-O-acetyl-alpha-D-galactopyranoside | C14H19BrO9 | 3068-32-4 | Details |
| H-CHMRSAMSGLHLVKRR-OH | Details |
| 3-Methyl-1-pentyl-1H-pyrazol-5-amine | C9H17N3 | 2629-98-3 | Details |
| L-Serine methyl ester HCl | C4H9NO3.ClH | 5680-80-8 | Details |
| 4-(4-Iodopyridin-2-yl)morpholine | C9H11IN2O | 1370025-59-4 | Details |
| 5-Chloro-2-methoxybenzoic methyl ester | C9H9ClO3 | 33924-48-0 | Details |
| ANP (Human, 7-28) | C100H153N33O30S3 | 96886-14-5 | Details |
| Elagolix hydroxy impurity | C31H28F5N3O5 | 832720-51-1 | Details |
| 4-Hydrazinyl-N-(1,3-thiazol-2-yl)benzene-1-sulfonamide dihydrochloride | C9H11ClN4O2S2 | 1375473-10-1 | Details |
| Betulonicacid | C30H46O3 | 4481-62-3 | Details |
| 1-Ethyl-3-methyl-1H-pyrazol-4-amine dihydrochloride | C6H11N3 | 947763-34-0 | Details |
| Human Plasma Pooled Unfiltered K2-EDTA | Details |
| Bisandrographolide | C40H56O8 | 160498-00-0 | Details |
| Guinea Pig RBC antibody (Texas Red) | Details |
| Methyl 4,5,7,8,9-penta-O-acetyl-2,6-anhydro-3-deoxy-D-glycero-D-galacto-non-2-enonate | C20H26O13 | 136737-07-0 | Details |
| 3-Methyl-2-phenylbutan-1-amine | C11H17N | 196106-01-1 | Details |
| H-NIIQFVHGEEDLK-OH | Details |
| Dynorphin A (3-8), porcine | C35H60N12O7 | Details |
| Cecropin B (free acid) trifluoroacetate salt | C176H301N51O42S | 203265-23-0 | Details |
| N'-Hydroxyoxolane-3-carboximidamide | C5H10N2O2 | 1251417-85-2 | Details |
| 2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]-3-hydroxypropyl valylvalinate | C19H31N7O6 | 897937-73-4 | Details |
| 4-(4-Chlorobenzenesulfonyl)piperazine-1-carbaldehyde | C11H13ClN2O3S | 928937-04-6 | Details |
| SLC6A4 antibody | Details |
| ALDOA Blocking Peptide | Details |
| Ethyl 8-fluoroimidazo[1,5-a]pyridine-3-carboxylate | C10H9FN2O2 | 2044713-85-9 | Details |
| Il6 protein | Details |
| N-Cyanomethylpyrrolidinium triflate | C7H11F3N2O3S | 573987-48-1 | Details |
| 12-Bromo-1-dodecanol | C12H25BrO | 3344-77-2 | Details |
| SSX5 antibody | Details |
| Sideroflexin 1 antibody | Details |
| N-Boc-(S)-2-(methylamino)butyric acid | C10H19NO4 | 101759-74-4 | Details |
| Desmethyl chlorpheniramine maleate salt | C19H21ClN2O4 | 22630-25-7 | Details |
| Fmoc-N-Amido-dPEG?36-TFP Ester | Details |
| ARALAR1 antibody | Details |
| 4-Methylbenzyl alcohol | C8H10O | 589-18-4 | Details |
| Cannabichromenic Acid | C22H30O4 | 185505-15-1 | Details |
| 2-(Chloromethyl)-6-fluoro-1H-1,3-benzodiazole-4-carboxylic acid hydrochloride | C9H7Cl2FN2O2 | 1193389-44-4 | Details |
| 4-Methylumbelliferyl 6-O-(tert-butyldiphenylsilyl)-b-D-galactopyranoside | C32H36O8Si | 296776-03-9 | Details |
| 4-(Pyridin-3-yl)piperidine-2,6-dione | C10H10N2O2 | 1267025-17-1 | Details |
| 2-(2,2-dimethylpropanoyl)-3-(4-nitrophenyl)prop-2-enenitrile | C14H14N2O3 | 150300-50-8 | Details |
| 4-Chloro-3-[(4-methoxyphenyl)sulfamoyl]benzoic acid | C14H12ClNO5S | 109029-99-4 | Details |
| 3-(2-Bromoethyl)-1-methyl-1H-indole | C11H12BrN | 61220-49-3 | Details |
| Slc9a3r2 Blocking Peptide | Details |
| 3-Amino-N,N-dimethyl-4-nitroaniline | C8H11N3O2 | 20691-71-8 | Details |
| Mafosfamide sodium | C9H20Cl2N2NaO5PS2 | 84211-05-2 | Details |
| Barbiturate antibody | Details |
| 3-(1,5-Dimethyl-1H-pyrazol-4-yl)-3-oxopropanenitrile | C8H9N3O | 1006485-37-5 | Details |
| [(1R,8S)-9-Bicyclo[6.1.0]non-4-ynyl]methyl N-(2-aminoethyl)carbamate | C13H20N2O2 | 2008714-39-2 | Details |
| [6-(Pyrrolidin-1-yl)pyridin-3-yl]boronic acid hydrochloride | C9H14BClN2O2 | 1485418-79-8 | Details |
| 2-(4-Butylbenzoyl)aniline | C17H19NO | 1225788-86-2 | Details |
| methyl 1-(bromomethyl)cyclopropane-1-carboxylate | C6H9BrO2 | 43161-30-4 | Details |
| Methyl 2-{[(propan-2-ylidene)amino]oxy}hexanoate | C10H19NO3 | 5001-41-2 | Details |
| XRCC3 Blocking Peptide | Details |
| 2-Hydroxy-5-methoxybenzaldehyde | C8H8O3 | 672-13-9 | Details |
| Ro2959 hydrochloride | C21H20ClF2N5OS | 1219927-22-6 | Details |
| 7-methoxy-8-hydroxy-4-phenylcoumarin | C16H12O4 | 24258-36-4 | Details |
| Methyl 6-O-tert-butyldimethylsilyl-2,3,4-tri-O-pivaloyl-a-D-glucopyranoside | C28H52O9Si | Details |
| 3,6-Dihydroxyflavone | C15H10O4 | 108238-41-1 | Details |
| Pterocarpadiol B | C16H14O6 | 2055882-20-5 | Details |
| {6-Oxabicyclo[3.2.1]octan-2-yl}methanamine hydrochloride | 2138204-86-9 | Details |
| Methyl 1-(2-{tricyclo[9.4.0.0,3,8]pentadeca-1(15),3,5,7,11,13-hexaen-2-yl}acetyl)piperidine-4-carboxylate | C24H27NO3 | 1069656-25-2 | Details |
| 1,3-bis(4-methylphenyl)-5-((2-methoxyphenyl)methylene)-1,3-diazaperhydroine-2,4,6-trione | C26H22N2O4 | 1023497-29-1 | Details |
| Lenperone hydrochloride | C22H24ClF2NO2 | 24677-86-9 | Details |
| GM 1489 | C27H33N3O4 | 171347-75-4 | Details |
| IL1 beta antibody (HRP) | Details |
| 1-(Pyrimidin-2-yl)piperidine-4-carbohydrazide | C10H15N5O | 685828-03-9 | Details |
| (S)-1-Benzyl-2-methyl-4,4-difluoropyrrolidine-1,2-dicarboxylic acid | C14H15F2NO4 | 72180-26-8 | Details |
| 3-Ethyl-1-(4-methyl-3-nitrophenyl)urea | C10H13N3O3 | 1600601-53-3 | Details |
| 2-Methyl-4-methylthiophenylboronic acid pinacol ester | C14H21BO2S | 1899905-99-7 | Details |
| Human Emmprin ELISA Kit | Details |
| 4-Ethylphenylacetone | C11H14O | 75251-24-0 | Details |
| 2-Methyl-4h-thieno[3,2-b]pyrrole-5-carboxylic acid | C8H7NO2S | 332099-14-6 | Details |
| PUF60 Blocking Peptide | Details |
| 5-Chloro-1-[(4-fluorophenyl)methyl]-3-methyl-1H-pyrazole-4-carbaldehyde | C12H10ClFN2O | 882238-93-9 | Details |
| Bis(1-methyl-1H-pyrazol-4-yl)methanamine | C9H13N5 | 1479117-62-8 | Details |
| 2-(2,4-Dimethylphenyl)pyrrolidine | C12H17N | 298690-87-6 | Details |
| 4-(2-Methyl-2 H -pyrazol-3-yl)-thiazol-2-ylamine | C7H8N4S | 957242-22-7 | Details |
| 1,3-Diethyl 2-propanoylpropanedioate | C10H16O5 | 21633-77-2 | Details |
| beta-Tocotrienol | C28H42O2 | 490-23-3 | Details |
| 3,3-Dimethyl-4-(piperidin-4-yl)azetidin-2-one | C10H18N2O | 1820665-59-5 | Details |
| 4-(Propan-2-yl)-4H-1,2,4-triazole-3-thiol | C5H9N3S | 38942-52-8 | Details |
| (1E)-1-(1-Ethyl-3,5-dimethyl-1H-pyrazol-4-yl)ethanone oxime | C9H15N3O | 943100-95-6 | Details |
| 2-Cyclopropylimidazo[1,2-a]pyridine-6-carboxylic acid | C11H10N2O2 | 1343134-57-5 | Details |
| 3-Amino-6-(difluoromethyl)-4-methylthieno[2,3-b]pyridine-2-carbonitrile | C10H7F2N3S | 942358-78-3 | Details |
| Allyl 2,3-di-O-benzyl-b-D-glucopyranoside | C23H28O6 | 84218-68-8 | Details |
| 2-Chloro-N-[(furan-2-yl)methyl]quinazolin-4-amine | C13H10ClN3O | 70128-51-7 | Details |
| Dammarenediol II | C30H52O2 | 14351-29-2 | Details |
| Naltrexone impurity F | C20H23NO5 | 2397651-97-5 | Details |
| H-STGSWSTLK-OH | Details |
| 1-Methyl-3-(piperidin-4-yl)-1H-1,2,4-triazol-5-amine dihydrochloride | C8H16ClN5 | 1795292-03-3 | Details |
| Altretamine-d18 | 65886-69-3 | Details |
| 3-Chloro-4,5-dimethoxyaniline hydrochloride | C8H11Cl2NO2 | 1909337-13-8 | Details |
| Pyrazolo[1,5-a]pyrimidine-7-carbonitrile | C7H4N4 | 1803597-11-6 | Details |
| Pigment yellow 182 | C22H20N6O8 | 67906-31-4 | Details |
| (6-Methoxybenzo[b]thiophen-2-yl)methanol | C10H10O2S | 912462-80-7 | Details |
| 3,3,5-Trimethyl-2-pyrrolidinone | C7H13NO | 87282-83-5 | Details |
| 1,3,4,6-Tetra-O-acetyl-N-(4-methoxybenzylidene)-b-D-glucosamine | C22H27NO10 | 7597-81-1 | Details |
| 3-[(1,3-Dioxo-2,3-dihydro-1H-isoindol-2-yl)methyl]-1H-pyrazole-4-carbaldehyde | C13H9N3O3 | 2044773-94-4 | Details |
| 5-Bromo-benzooxazole-2-carbaldehyde | C8H4BrNO2 | 944907-38-4 | Details |
| 4-[(Methylsulfanyl)methyl]cyclohexan-1-amine hydrochloride | C8H18ClNS | 1820639-48-2 | Details |
| Product Total： Product Page： | ||||
| 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 | ||||